Related Experiment Videos
Kawasaki disease: an update
I Nasr1, A J Tometzki, O M Schofield
1Department of Dermatology, Royal Infirmary of Edinburgh, Edinburgh, Scotland, UK.
Insights
Kawasaki disease, a vasculitis causing prolonged fever and rash in children, can lead to acquired heart disease. Early treatment with intravenous immunoglobulin and aspirin significantly reduces coronary complications.
Area of Science:
- Pediatric Rheumatology
- Immunology
- Cardiology
Background:
- Kawasaki disease is a leading cause of acquired heart disease in children.
- It presents with prolonged fever and a characteristic rash.
- The exact etiology remains unknown, with superantigen exposure being a hypothesis.
Purpose of the Study:
- To summarize the key aspects of Kawasaki disease.
- To highlight diagnostic criteria and the role of investigations.
- To emphasize the importance of timely treatment for preventing cardiac complications.
Main Methods:
- Diagnosis relies on established clinical criteria.
- Investigations focus on excluding other conditions and assessing cardiac involvement.
- Treatment involves intravenous immunoglobulin and oral aspirin.
Main Results:
- Intravenous immunoglobulin therapy combined with oral aspirin significantly reduces coronary artery complications.
- Prompt diagnosis and treatment are crucial for favorable outcomes.
- Awareness of Kawasaki disease is vital for managing childhood exanthems.
Conclusions:
- Kawasaki disease requires prompt recognition and management.
- Effective treatment strategies exist to mitigate serious cardiac sequelae.
- Continued research into its etiology is warranted.
Abstract:
Kawasaki disease is one of the commonest vasculitides seen in children. It presents with prolonged fever and a polymorphic exanthem. It is a major cause of acquired heart disease in western society. Its exact cause is not known, but exposure to a superantigen has been suggested as a possible aetiological factor. Diagnosis of Kawasaki disease still relies on clinical criteria (Table 1) and investigations are done mainly to exclude other diseases and to detect early or established cardiac complications. Coronary complications can be reduced significantly by the use of intravenous immunoglobulin therapy combined with oral aspirin. The serious consequences of Kawasaki disease require a heightened awareness of this condition when dealing with childhood exanthems.